DOI: https://doi.org/10.24026/1818-1384.1(22).2008.118399

Розчинний рецептор кінцевих продуктів посиленого глікування у хворих на цукровий діабет 2-го типу: зв'язок з інсулінорезистентністю

М. Ю. Горшунська, Ю. І. Караченцев, Н. С. Краснова, Е. Йенсен, О. І. Гладких, В. В. Полторак

Повний текст:

PDF

Посилання


Bucciarelli L.G., Wendt T., Rong L. et al. RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease // Cell Mol. Life Sci. — 2002. — Vol. 59. — P. 1117-1128.

Schlueter C., Hauke S., Flohr A.M. et al. Tissue specific expression patterns of the RAGE receptor and its soluble form — a result of regulated alternative splicing? // Biochem. Biophys. Acta. — 2003. — Vol. 1639. — P. 1-6.

Neeper M., Schmidt A.M., Brett J. et al. Cloning and Expression of a cell surface receptor for advanced glycosylation end products of proteins // J. Biol. Chem. — 1992. — Vol. 267. — P. 14998-15004.

Bierhaus A., Humpert P.M., Morcos M. et al. Understanding RAGE, the receptor for advanced glycation end products // J. Mol. Med. — 2005. — Vol. 83. — P. 876-886.

Singh R., Barden A., Mori T., Beilin L. Advanced glycation end-products: a review // Diabetologia. — 2001. — Vol. 44, No 2. — P. 129—146.

Stern D.M., Yan S.D., Yan S.F., Schmidt A.M. Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes // Ageing Res. Rev. — 2002. — Vol. 1, No 1. — P. 1-15.

Yamamoto Y., Yamagishi S., Yonekura H. et al. Roles of the AGE-RAGE system in vascular injury in diabetes // Ann. N. Y. Acad. Sci. — 2000. — Vol. 902. — P. 163-170.

Basta G., Lazzerini G., Massaro M. et al. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses // Circulation. — 2002. — Vol. 105. — P. 816-822.

Tanaka N., Yonekura H., Yamagishi S. et al. The receptor for advanced glycation end producs is induced by the glycation product themselves and tumor necrosis factor-α through nuclear factor-κ B, and by 17β-estradiol through Sp-1 in human vascular endothelial cells // J. Biol. Chem. — 2000. — Vol. 275. — P. 25781-25790.

Hudson B.I., Bucciarelli L.G., Wendt T. et al. Blockade of receptor for advanced glycation endproducs: a new target for therapeutic intervention in diabetic complications and inflammatory disorders // Arch. Biochem. Biophys. — 2003. — Vol. 419. — P. 80-88.

Goosa M.T., Li J., Kislinger T. et al. Blockade of receptor for Advanced Glycation Endproducts restores effective wound healing in diabetic mice // Amer. J. Pathol. — 2001 — Vol. 159. — P. 513-525.

Kalousova M., Hodkova M., Kazderova M. et al. Soluble receptor for advanced glycation end products in patients with decreased renal function // Amer. J. Kidney Dis. — 2006. — Vol. 47. — P. 406-411.

Tan K.C.B., Shiu S.W.M., Chow W.S. et al. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes // Diabetologia. — 2006. — Vol. 49, No 11. — P. 2756-2762.

Challier M., Jacqueminet S., Benabdesselam O. et al. Increased serum concentration of soluble receptor for advanced glycation endproducts in patients with type 1 diabetes // Clin. Chem. — 2005. — Vol. 51. — P. 1749-1750.

Basta G., Sironi A.M., Lazzerini G. et al. Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein // J. Clin. Endocrinol. Metab. — 2006. — Vol. 91. — P. 4528-4534.

Tan K.C.B., Chow W.S., Tso A.W.K. et al. Thiazolidinedione increases serum soluble receptor for advanced glycation end-products in type 2 diabetes // Diabetologia. — 2007. — Vol. 50, No 9. — P. 1819-1825.

Matthews D.R., Hosker J.P., Rudenski A.S. et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man // Diabetologia. — 1985. — Vol. 28. — P. 412-419.

Matsuhisa M., Yamasaki Y., Emoto M. et al. A novel index of insulin resistance determined from the homeostasis model assessment index and adiponectin levels in Japanese subjects // Diabetes Res. Clin. Pract. — 2007. — Vol. 77. — P. 151-154.

Katz A., Nambi S.S. Mather K. et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans // J Clin Endocrin Metab. — 2000. — Vol. 85. — P. 2402-2410.

Inoue M., Yano M., Yamakado M. et al. Relationship between the adiponectin-leptin ratio and parameters of insulin resistance in subjects without hyperglycemia // Metabolism. — 2006. — Vol. 55. — P. 1248-1254.

Hudson B.I., Harja E., Moser B., Schmidt A.M. Soluble levels of receptor for advanced glycation endproducs (sRAGE) and coronary artery disease: the next C-reactive protein? // Arterioscler. Thromb. Vasc. Biol. — 2005. — Vol. 25. — P. 897-882.

Koyama H., Shoji T., Yokoyama H. et al. Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis // Arterioscler. Thromb. Vasc. Biol. — 2005. — Vol. 25. — P. 2587-2593.

Dimascio L., Voermans C., Uqoezwa M. et al. Identification of adiponectin as a novel hemopoetic stem cell growth factor // J. Immunol. — 2007. — Vol. 178, No 6. — P. 3511-3520.


Пристатейна бібліографія ГОСТ








Creative Commons License
Ця робота ліцензована Creative Commons Attribution-NonCommercial 4.0 International License.

© Клінічна ендокринологія та ендокринна хірургія.

ISSN: 1818-1384 (Print), e-ISSN: 2519-2582, DOI: 10.24026/1818-1384.

При копіюванні активне посилання на матеріал обов'язкове.

Flag Counter